TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Waxman Adds NIH Bypass Budget To Authorization Bill, OKs$1.32 Billion for NCI In FY 1984 April 1, 1983
TCL Archive Chart Show 1980 Budget Breakown By Mechanisms, Research Programs, Compare Them With Previous Years June 9, 1978
TCL Archive In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief April 12, 1974
TCL Archive Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says. August 1, 2008
